This innovative treatment synergistically combines a fully human monoclonal antibody, aimed at the GIP receptor (GIPR) a target for blood sugar control with a GLP-1 agonist peptide analog , which is a molecule designed to stimulate insulin release [Vniant, M.M
Here is what it does: Tells your pancreas to release insulin, which lowers blood sugar Slows how fast your food leaves your stomach, so you feel full longer Sends signals to your brain to reduce feelings of hunger Some weight-loss and diabetes medications are called GLP-1 receptor agonists, which means they copy this natural hormone and boost its effects
They may even be able to change food preferences or decrease the desire to reach for unhealthy sweets and fatty foods
Hong J, Zhang Y, Lai S, Lv A, Su Q, Dong Y, Zhou Z, Tang W, Zhao J, Cui L, Zou D, Wang D, Li H, Liu C, Wu G, Shen J, Zhu D, Wang W, Shen W, Ning G
If you are ready to see whether prescription GLP-1 treatment is a fit for you, you can take our free assessment quiz while you read
Where MEDVi wins on value Review volume and ratings tell a story